HCA Healthcare, Inc. (HCA)

Basic

  • Market Cap

    $68.83B

  • EV

    $111.79B

  • Shares Out

    267.66M

  • Revenue

    $63.16B

  • Employees

    250,500

Margins

  • Gross

    38.7%

  • EBITDA

    19.44%

  • Operating

    14.63%

  • Pre-Tax

    13.72%

  • Net

    9.05%

  • FCF

    6.93%

Returns (5Yr Avg)

  • ROA

    10.95%

  • ROE

    228.05%

  • ROCE

    21.45%

  • ROIC

    17.17%

Valuation (TTM)

  • P/E

    —

  • P/B

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • EV/FCF

    —

  • EV/Gross Profit

    —

Valuation (NTM)

  • Price Target

    $281.53

  • P/E

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • EV/FCF

    —

Per Share

  • Rev

    $229.02

  • Earnings (Dil)

    $20.41

  • FCF

    $15.63

  • Book Value

    -$9.21

Growth (CAGR)

  • Rev 3Yr

    7.56%

  • Rev 5Yr

    6.56%

  • Rev 10Yr

    6.46%

  • Dil EPS 3Yr

    27.31%

  • Dil EPS 5Yr

    17.97%

  • Dil EPS 10Yr

    20.66%

  • Rev Fwd 2Yr

    5.99%

  • EBITDA Fwd 2Yr

    3.92%

  • EPS Fwd 2Yr

    7.88%

  • EPS LT Growth Est

    8.52%

Dividends

  • Yield

    —

  • Payout

    11.39%

  • DPS

    $2.36

  • DPS Growth 3Yr

    41.67%

  • DPS Growth 5Yr

    17.58%

  • DPS Growth 10Yr

    —

  • DPS Growth Fwd 2Yr

    5.65%

Select a metric from the list below to chart it

Dec '13
Dec '15
Dec '17
Dec '19
Dec '21
LTM
Metric
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
LTM

Total Revenues

46,677.0

51,336.0

51,533.0

58,752.0

60,233.0

63,162.0

Total Revenues % Chg.

7.0%

10.0%

0.4%

14.0%

2.5%

5.6%

Cost of Goods Sold, Total

29,149.0

32,041.0

32,243.0

36,260.0

37,056.0

38,719.0

Gross Profit

17,528.0

19,295.0

19,290.0

22,492.0

23,177.0

24,443.0

Selling General & Admin Expenses, Total

—

855.0

923.0

989.0

976.0

976.0

Depreciation & Amortization

2,278.0

2,596.0

2,721.0

2,853.0

2,969.0

3,038.0

Other Operating Expenses

8,608.0

8,626.0

8,384.0

8,972.0

10,179.0

11,190.0

Other Operating Expenses, Total

10,886.0

12,077.0

12,028.0

12,814.0

14,124.0

15,204.0

Operating Income

6,642.0

7,218.0

7,262.0

9,678.0

9,053.0

9,239.0

Interest Expense, Total

-1,755.0

-1,824.0

-1,584.0

-1,566.0

-1,741.0

-1,900.0

Net Interest Expenses

-1,755.0

-1,824.0

-1,584.0

-1,566.0

-1,741.0

-1,900.0

Income (Loss) On Equity Invest.

29.0

43.0

54.0

113.0

45.0

10.0

EBT, Excl. Unusual Items

4,916.0

5,437.0

5,732.0

8,225.0

7,357.0

7,349.0

Gain (Loss) On Sale Of Investments

—

—

—

—

—

—

Gain (Loss) On Sale Of Assets

428.0

18.0

-7.0

1,620.0

1,301.0

1,314.0

Legal Settlements

—

—

—

—

—

—

Other Unusual Items

-9.0

-211.0

-295.0

-12.0

-78.0

—

EBT, Incl. Unusual Items

5,335.0

5,244.0

5,430.0

9,833.0

8,580.0

8,663.0

Income Tax Expense

946.0

1,099.0

1,043.0

2,112.0

1,746.0

1,787.0

Earnings From Continuing Operations

4,389.0

4,145.0

4,387.0

7,721.0

6,834.0

6,876.0

Minority Interest

-602.0

-640.0

-633.0

-765.0

-1,191.0

-1,160.0

Net Income

3,787.0

3,505.0

3,754.0

6,956.0

5,643.0

5,716.0

Net Income to Common Incl Extra Items

3,787.0

3,505.0

3,754.0

6,956.0

5,643.0

5,716.0

Net Income to Common Excl. Extra Items

3,787.0

3,505.0

3,754.0

6,956.0

5,643.0

5,716.0

Total Shares Outstanding

342.9

338.4

339.4

305.5

277.4

269.0

Weighted Avg. Shares Outstanding

347.3

341.2

338.3

323.3

290.3

275.8

Weighted Avg. Shares Outstanding Dil

355.3

348.2

343.6

328.8

294.7

280.0

EPS

10.9

10.3

11.1

21.5

19.4

20.7

EPS Diluted

10.7

10.1

10.9

21.2

19.2

20.4

EBITDA

8,920.0

9,814.0

9,983.0

12,531.0

12,022.0

12,277.0